Reliability and Validity of the Turkish Language Version of the International Consultation on Incontinence Questionnaire - Male Lower Urinary Tract Symptoms

Oğuz Mertoğlu, Oktay Üçer, Yasin Ceylan, Ozan Bozkurt, Bülent Günlüsoy, Ali Can Albaz, Ömer Demir, Aegean Study Group of Society of Urological Surgery, Oğuz Mertoğlu, Oktay Üçer, Yasin Ceylan, Ozan Bozkurt, Bülent Günlüsoy, Ali Can Albaz, Ömer Demir, Aegean Study Group of Society of Urological Surgery

Abstract

Purpose: Patients receiving treatment for benign prostate hyperplasia may have persistent storage symptoms. There has been increasing debate on the precision and accuracy of the International Prostate Symptom Score questionnaires over other questionnaires in evaluating all the complaints of lower urinary tract symptoms (LUTS). The aim of this study was to perform the validity and reliability analysis of the Turkish version of the Internatinal Consultation on Incontinence Questionnaire-Male LUTS (ICIQ-MLUTS).

Methods: Linguistic validation was studied (i.e., translation and back translation). Intelligibility was completed between October 2013 and November 2013. Data was collected between November 2013 and March 2014. The stability and reliability of the form were measured with the Cronbach test.

Results: In total, 117 male patients were included in the study. At the first visit, the mean age of the patients was 59 years (range, 18-84 years). For reliability, the Cronbach alpha value was 0.798, demonstrating the internal consistency of the form (r>0.7). The internal consistency of each question was examined separately and found to be over 0.7. For the evaluation of test-retest reliability, the test was administered to 116 patients for a second time with an interval of 2-4 weeks. The first and second test scores for each question were found to be correlated (r=0.741).

Conclusions: ICIQ-MLUTS is a new questionnaire, which can be used for evaluating male LUTS in Turkey. We believe that the Turkish version of the ICIQ-MLUTS is an important breakthrough in our country.

Keywords: Lower Urinary Tract Symptoms; Male; Questionnaire; Validation.

Conflict of interest statement

Conflict of Interest

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1.
Fig. 1.
Correlation graph of the test-retest results.

References

    1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37–49.
    1. Barry MJ, Fowler FJ, Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148:1549–57.
    1. Cockett AT, Khoury S, Aso Y. The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH); 1993 June 27-30; Paris, France. Jersey: Scientific Communication International; 1993.
    1. Liao CH, Chung SD, Kuo HC. Diagnostic value of International Prostate Symptom Score voiding-to-storage subscore ratio in male lower urinary tract symptoms. Int J Clin Pract. 2011;65:552–8.
    1. Yap TL, Cromwell DA, Brown C, van der Meulen J, Emberton M. The relationship between objective frequency-volume chart data and the I-PSS in men with lower urinary tract symptoms. Eur Urol. 2007;52:811–8.
    1. Meyhoff HH, Hald T, Nordling J, Andersen JT, Bilde T, Walter S. A new patient weighted symptom score system (DAN-PSS-1). Clinical assessment of indications and outcomes of transurethral prostatectomy for uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol. 1993;27:493–9.
    1. Bosch R, Abrams P, Cotteril N, Gotoh M, Nitti V, Novara G, et al. Lower urinary tract symptoms in men: etiology, patient assessment and predicting outcome from therapy. In: Chapple C, Abrams P, editors. Male lower urinary tract symptoms (LUTS). An International Consultation on Male LUTS; 2012 Sep 30-Oct 4; Fukuoka, Japan. Montreal: Societe Internationale Urologie (SIU); 2013. pp. 37–133.
    1. Donovan JL, Abrams P, Peters TJ, Kay HE, Reynard J, Chapple C, et al. The ICS-’BPH’ Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol. 1996;77:554–62.
    1. DeVon HA, Block ME, Moyle-Wright P, Ernst DM, Hayden SJ, Lazzara DJ, et al. A psychometric toolbox for testing validity and reliability. J Nurs Scholarsh. 2007;39:155–64.
    1. Kaplan SA, Roehrborn CG, Chapple CR, Rosen RC, Irwin DE, Kopp Z, et al. Implications of recent epidemiology studies for the clinical management of lower urinary tract symptoms. BJU Int. 2009;103 Suppl 3:48–57.
    1. Donovan JL, Brookes ST, de la Rosette JJ, Peters TJ, Porru D, Kondo A, et al. The responsiveness of the ICSmale questionnaire to outcome: evidence from the ICS-’BPH’ study. BJU Int. 1999;83:243–8.
    1. Donovan JL, Peters TJ, Abrams P, Brookes ST, de aa Rosette JJ, Schafer W. Scoring the short form ICSmaleSF questionnaire. International Continence Society. J Urol. 2000;164:1948–55.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever